Karyopharm Therapeutics Inc (NASDAQ: KPTI) started the day on Wednesday, with a price increase of 7.07% at $7.87, before settling in for the price of $7.35 at the close. Taking a more long-term approach, KPTI posted a 52-week range of $3.51-$12.15.
It was noted that the giant of the Healthcare sector posted annual sales growth of 27.91% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 27.91%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 12.70%. This publicly-traded company’s shares outstanding now amounts to $18.31 million, simultaneously with a float of $17.08 million. The organization now has a market capitalization sitting at $144.10 million. At the time of writing, stock’s 50-day Moving Average stood at $6.25, while the 200-day Moving Average is $5.49.
Karyopharm Therapeutics Inc (KPTI) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Karyopharm Therapeutics Inc’s current insider ownership accounts for 6.73%, in contrast to 37.77% institutional ownership. According to the most recent insider trade that took place on Oct 01 ’25, this organization’s Chief Accounting Officer sold 362 shares at the rate of 6.30, making the entire transaction reach 2,279 in total value, affecting insider ownership by 10,046. Preceding that transaction, on Sep 15 ’25, Company’s President and CEO sold 1,257 for 6.43, making the whole transaction’s value amount to 8,083. This particular insider is now the holder of 84,046 in total.
Karyopharm Therapeutics Inc (KPTI) Earnings and Revenue Records
Karyopharm Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 12.70% and is forecasted to reach -5.90 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 49.66% through the next 5 years, which can be compared against the 27.91% growth it accomplished over the previous five years trading on the market.
Karyopharm Therapeutics Inc (NASDAQ: KPTI) Trading Performance Indicators
Let’s observe the current performance indicators for Karyopharm Therapeutics Inc (KPTI). It’s Quick Ratio in the last reported quarter now stands at 0.98. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.01.
In the same vein, KPTI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -14.58, a figure that is expected to reach -2.08 in the next quarter, and analysts are predicting that it will be -5.90 at the market close of one year from today.
Technical Analysis of Karyopharm Therapeutics Inc (KPTI)
If we take a close look at the recent performances of Karyopharm Therapeutics Inc (NASDAQ: KPTI), its last 5-days Average volume was 0.35 million that shows plunge from its year to date volume of 0.4 million. During the previous 9 days, stock’s Stochastic %D was recorded 66.65% While, its Average True Range was 72.82.
Raw Stochastic average of Karyopharm Therapeutics Inc (KPTI) in the period of the previous 100 days is set at 92.31%, which indicates a major rise in contrast to 87.04% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.46 that was lower than 0.54 volatility it exhibited in the past 100-days period.
